SIP
GNMK

Stoneridge Investment Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

Stoneridge Investment Partners’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,989
Closed -$154K – 333
2017
Q1 		$154K Sell
11,989
-4,764
-28% -$57.3K 0.02% 292
2016
Q4 		$205K Sell
16,753
-291
-2% -$3.46K 0.03% 268
2016
Q3 		$201K Sell
17,044
-14,110
-45% -$136K 0.03% 245
2016
Q2 		$271K Hold
31,154
– – 0.04% 235
2016
Q1 		$164K Buy
31,154
+11,386
+58% +$63.4K 0.02% 272
2015
Q4 		$153K Sell
19,768
-1,784
-8% -$13.7K 0.02% 266
2015
Q3 		$170K Buy
+21,552
New +$199K 0.02% 264

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stoneridge Investment Partners's GNMK Position: Q2 2017 in Review

Stoneridge Investment Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2017, closing a stake of 11,989 shares — an estimated $154K sold.

Stoneridge Investment Partners first reported a position in GNMK in Q3 2015 and held it in 7 quarters. The position peaked at $271K in Q2 2016. 99 funds tracked by Wall St. Rank hold GNMK as of Q2 2017.

  • Stoneridge Investment Partners reported no remaining GenMark Diagnostics, Inc position as of Q2 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 11,989 GenMark Diagnostics, Inc shares in Q2 2017, an estimated $154K.
  • Stoneridge Investment Partners first reported a position in GenMark Diagnostics, Inc in Q3 2015 and held it in 7 quarters.
  • Stoneridge Investment Partners's GenMark Diagnostics, Inc position peaked at $271K in Q2 2016.
  • 99 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2017.

Based on Stoneridge Investment Partners's 13F filing for Q2 2017, filed 1 Aug 2017.